Cost analysis of divalproex sodium extended-release compared to valproic acid in the treatment of bipolar disorder

Author： Schumock Glen T. Walton Surrey M. Gupta Shiraz R. Cramer Joyce A.

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.23, Iss.8, 2007-08, pp. : 1997-2004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carbamazepine extended-release capsules for the treatment of bipolar I disorder

By Weisler Richard H

Therapy, Vol. 2, Iss. 4, 2005-07 ,pp. : 533-544

Future Medicine

Access to resources Recommend Favorite

Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet

By Garikipati Vandana Toops Dana S. Fang Qi

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1869-1876

Informa Healthcare

Access to resources Recommend Favorite

Cost effectiveness of duloxetine compared with venlafaxine-XR in the treatment of major depressive disorder

By van Baardewijk M. Vis P. M. J. Einarson T. R.

Current Medical Research and Opinion, Vol. 21, Iss. 8, 2005-08 ,pp. : 1271-1280

Informa Healthcare

Access to resources Recommend Favorite

Memantine Standard Tablet and Extended‐Release Dosing Considerations: A Pharmacokinetic Analysis

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 63, Iss. 2, 2015-02 ,pp. : 383-384

John Wiley & Sons Inc

Access to resources Recommend Favorite

Test–retest reliability of schizoaffective disorder compared with schizophrenia, bipolar disorder, and unipolar depression—a systematic review and meta‐analysis

BIPOLAR DISORDERS (ELECTRONIC), Vol. 17, Iss. 7, 2015-11 ,pp. : 753-768

John Wiley & Sons Inc

Access to resources Recommend Favorite